265 related articles for article (PubMed ID: 11900240)
1. Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.
Eberhart CG; Kepner JL; Goldthwaite PT; Kun LE; Duffner PK; Friedman HS; Strother DR; Burger PC
Cancer; 2002 Jan; 94(2):552-60. PubMed ID: 11900240
[TBL] [Abstract][Full Text] [Related]
2. Histopathologic grading of adult medulloblastomas.
Rodriguez FJ; Eberhart C; O'Neill BP; Slezak J; Burger PC; Goldthwaite P; Wu W; Giannini C
Cancer; 2007 Jun; 109(12):2557-65. PubMed ID: 17487854
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of anaplasia and angiogenesis in childhood medulloblastoma: a pediatric oncology group study.
Ozer E; Sarialioglu F; Cetingoz R; Yüceer N; Cakmakci H; Ozkal S; Olgun N; Uysal K; Corapcioglu F; Canda S
Pathol Res Pract; 2004; 200(7-8):501-9. PubMed ID: 15462497
[TBL] [Abstract][Full Text] [Related]
4. Stratification of medulloblastoma on the basis of histopathological grading.
Giangaspero F; Wellek S; Masuoka J; Gessi M; Kleihues P; Ohgaki H
Acta Neuropathol; 2006 Jul; 112(1):5-12. PubMed ID: 16685513
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastomas with favorable versus unfavorable histology: how many small blue cell tumor types are there in the brain?
Perry A
Adv Anat Pathol; 2002 Nov; 9(6):345-50. PubMed ID: 12409643
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic grading of medulloblastomas.
Ho DM; Hsu CY; Chiang H
Cancer; 2002 Dec; 95(12):2577-8; author reply 2578-9. PubMed ID: 12467073
[No Abstract] [Full Text] [Related]
7. Anaplasia is rare and does not influence prognosis in adult medulloblastoma.
Giordana MT; D'Agostino C; Pollo B; Silvani A; Ferracini R; Paiolo A; Ghiglione P; Chiò A
J Neuropathol Exp Neurol; 2005 Oct; 64(10):869-74. PubMed ID: 16215458
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior.
Min HS; Lee YJ; Park K; Cho BK; Park SH
Acta Neuropathol; 2006 Jul; 112(1):13-20. PubMed ID: 16691420
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis for histopathological subtypes in pediatric medulloblastomas.
Son EI; Kim IM; Kim DW; Yim MB; Kang YN; Lee SS; Kwon KY; Suh SI; Kwon TK; Lee JJ; Kim DS; Kim SP
Pathol Int; 2003 Feb; 53(2):67-73. PubMed ID: 12588433
[TBL] [Abstract][Full Text] [Related]
10. A cytomorphological scheme of differentiating neuronal phenotypes in cerebellar medulloblastomas based on immunolocalization of class III beta-tubulin isotype (beta III) and proliferating cell nuclear antigen (PCNA)/cyclin.
Katsetos CD; Krishna L; Frankfurter A; Karkavelas G; Wolfe DE; Valsamis MP; Schiffer D; Vlachos IN; Urich H
Clin Neuropathol; 1995; 14(2):72-81. PubMed ID: 7606900
[TBL] [Abstract][Full Text] [Related]
11. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
[TBL] [Abstract][Full Text] [Related]
12. Medulloblastoma with lipidized cells versus lipomatous medulloblastoma.
Giordana MT; Schiffer P; Boghi A; Buoncristiani P; Benech F
Clin Neuropathol; 2000; 19(6):273-7. PubMed ID: 11128619
[TBL] [Abstract][Full Text] [Related]
13. [Expression and clinical significance of cyclooxygenase-2 in medulloblastoma].
Deng QJ; Mao BY; Zhang SF; Tang J; Wang ER
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):641-3. PubMed ID: 15460407
[TBL] [Abstract][Full Text] [Related]
14. Calbindin-d(28k): a marker of recurrence for medulloblastomas.
Pelc K; Vincent S; Ruchoux MM; Kiss R; Pochet R; Sariban E; Decaestecker C; Heizmann CW
Cancer; 2002 Jul; 95(2):410-9. PubMed ID: 12124842
[TBL] [Abstract][Full Text] [Related]
15. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of apoptosis in medulloblastoma.
Pizem J; Cör A; Zadravec Zaletel L; Popovic M
Neurosci Lett; 2005 Jun 10-17; 381(1-2):69-73. PubMed ID: 15882792
[TBL] [Abstract][Full Text] [Related]
17. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
Pan E; Pellarin M; Holmes E; Smirnov I; Misra A; Eberhart CG; Burger PC; Biegel JA; Feuerstein BG
Clin Cancer Res; 2005 Jul; 11(13):4733-40. PubMed ID: 16000568
[TBL] [Abstract][Full Text] [Related]
18. Morphophenotype of medulloblastoma in children and adults. The size of nuclei.
Dagostino C; Clara E; Chio A; Giordana MT
Clin Neuropathol; 2006; 25(5):227-31. PubMed ID: 17007445
[TBL] [Abstract][Full Text] [Related]
19. [Glial fibrillary acidic protein and neurofilament protein in medulloblastoma].
Tohyama T; Kubo O; Katahira M; Sakairi M; Tajika T; Tajika Y; Kitamura K
No Shinkei Geka; 1988 Oct; 16(11):1243-50. PubMed ID: 3145467
[TBL] [Abstract][Full Text] [Related]
20. Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virus.
Eberhart CG; Chaudhry A; Daniel RW; Khaki L; Shah KV; Gravitt PE
BMC Cancer; 2005 Feb; 5():19. PubMed ID: 15717928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
